[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells]

Ned Tijdschr Geneeskd. 1989 Jul 15;133(28):1392-5.
[Article in Dutch]
No abstract available

Publication types

  • Clinical Trial
  • Review

MeSH terms

  • Clinical Trials as Topic
  • Humans
  • Immunization, Passive* / adverse effects
  • Interleukin-2 / adverse effects
  • Interleukin-2 / therapeutic use*
  • Killer Cells, Lymphokine-Activated*
  • Neoplasms / therapy*

Substances

  • Interleukin-2